[The role of erythrocytes in the pathogenesis of functional disorders of blood platelets in patients with ischemic heart disease and the possibilities of their pharmacological correction].
M V
MV
Leonova
V B
VB
Razumov
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors / Q000097:blood* / Q000378:metabolism; D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D010973:Platelet Adhesiveness / Q000187:drug effects / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D000244:Adenosine Diphosphate
Rol' éritrotsitov v patogeneze narusheniia funktsional'noĭ aktivnosti trombotsitov u bol'nykh ishemicheskoĭ bolezn'iu serdtsa i vozmozhnosti medikamentoznoĭ korrektsii.